Loracarbef is a synthetic "carba" analog of cefaclor, and is more stable. Loracarbef received FDA approval in 1991 and it was marketed under the trade name Lorabid. Its use was discontinued in 2006. [citation needed] Loracarbef was used to treat infections of the lungs, maxillary sinuses, throat, skin, and urinary tract. [2]

氯碳头孢，英文名是Loracarbef，是一种化学物质，化学式为C16H16ClN3O4。 1.支气管炎（包括急性支气管炎和慢性支气管炎急性发作）。 2.肺炎。 3.咽炎。 4.中耳炎。 5.鼻窦炎。 6.皮肤及皮下组织感染（如脓疱疮）。 7.尿路感染（如膀胱炎、肾盂肾炎）。 [2] 1.药效学：本药为1-碳头孢烯β-内酰胺类抗生素，属于口服二代头孢菌素。 作用机制：本药作用机制与其他β-内酰胺类抗生素相似，通过与一个或多个青霉素结合蛋白（PBPs）结合，抑制细菌细胞壁的合成。 本药主要 …

2025年2月1日 · Loracarbef is used to treat bacterial infections in many different parts of the body. It works by killing bacteria or preventing their growth. This medicine will not work for colds, flu, or other virus infections. Loracarbef is available only with your doctor's prescription.

2022年8月11日 · Loracarbef is a synthetic b-lactam antibiotic of the carbacephem class for oral administration. Chemically, carbacephems differ from cephalosporin-class antibiotics in the dihydrothiazine ring where a methylene group has been substituted for a sulfur atom.

Loracarbef is an oral, synthetic beta-lactam antibiotic of the carbacephem class. Chemically, carbacephems differ from cephalosporin-class antibiotics in the dihydrothiazine ring where a methylene group has been substituted for a sulfur atom. Loracarbef has a spectrum of activity similar to that of the second generation cephalosporins.

2024年3月25日 · Lorabid ® (loracarbef, USP) is a syntheticβ-lactam antibiotic of the carbacephem class for oral administration. Chemically, carbacephems differ from cephalosporin-class antibiotics in the dihydrothiazine ring where a methylene group has been substituted for a sulfur atom.

Information on Loracarbef (Lorabid), a drug prescribed for the treatment of bacterial infections such as sinusitis, middle ear, tonsillitis, bronchitis, sore throat, and pneumonia. Read more about the prescription drug Loracarbef (Lorabid).

Data synthesis: Loracarbef has antibacterial activity against most community-acquired respiratory tract, skin and skin structure, and urinary tract pathogens. The drug is well absorbed after oral administration and plasma concentrations achieved in patients are greater than the in vitro minimum inhibitory concentrations for most of the above ...

Loracarbef is a synthetic "carba" analogue of cefaclor, with carbon replacing sulfur at position 1. Used to treat a wide range of infections caused by both gram-positive and gram-negative bacteria. It has a role as an antibacterial drug and an antimicrobial agent. It is a conjugate acid of a loracarbef anion. It is a tautomer of a loracarbef ...

氯碳头孢: 一种PBPs抑制剂药物，由Eli Lilly & Co. (Eli Lilly & Co.)公司最早进行研发，目前全球最高研发状态为撤市，作用机制: PBPs抑制剂 (细菌青霉素结合蛋白家族抑制剂)，治疗领域: 感染,耳鼻咽喉疾病,呼吸系统疾病。